Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2009
Published online before print January 8, 2009, doi: 10.1161/CIRCRESAHA.108.181651
A more recent version of this article appeared on February 27, 2009
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
104/4/514    most recent
CIRCRESAHA.108.181651v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Terentyev, D.
Right arrow Articles by Gyorke, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terentyev, D.
Right arrow Articles by Gyorke, S.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Arrhythmia
Related Collections
Right arrow Arrythmias-basic studies
Right arrow Calcium cycling/excitation-contraction coupling
Right arrowRelated Article

Submitted on June 16, 2008
Revised on December 8, 2008
Accepted on December 30, 2008

miR-1 Overexpression Enhances Ca2+ Release and Promotes Cardiac Arrhythmogenesis by Targeting PP2A Regulatory Subunit B56{alpha} and Causing CaMKII-Dependent Hyperphosphorylation of RyR2

Dmitry Terentyev *; Andriy E. Belevych ; Radmila Terentyeva ; Mickey M. Martin ; Geraldine E. Malana ; Donald E. Kuhn ; Maha Abdellatif ; David S. Feldman ; Terry S. Elton ; and Sandor Gyorke

From the Davis Heart and Lung Research Institute (D.T., A.E.B., R.T., M.M.M., G.E.M., D.E.K., D.S.F., T.S.E., S.G.), Ohio State University, Columbus; and Cardiovascular Research Institute (M.A.), Department of Cell Biology and Molecular Medicine, University of Medicine and Dentistry of New Jersey, Newark.

* To whom correspondence should be addressed. E-mail: Dmitry.Terentyev{at}osumc.edu.

MicroRNAs are small endogenous noncoding RNAs that regulate protein expression by hybridization to imprecise complementary sequences of target mRNAs. Changes in abundance of muscle-specific microRNA, miR-1, have been implicated in cardiac disease, including arrhythmia and heart failure. However, the specific molecular targets and cellular mechanisms involved in the action of miR-1 in the heart are only beginning to emerge. In this study we investigated the effects of increased expression of miR-1 on excitation–contraction coupling and Ca2+ cycling in rat ventricular myocytes using methods of electrophysiology, Ca2+ imaging and quantitative immunoblotting. Adenoviral-mediated overexpression of miR-1 in myocytes resulted in a marked increase in the amplitude of the inward Ca2+ current, flattening of Ca2+ transients voltage dependency, and enhanced frequency of spontaneous Ca2+ sparks while reducing the sarcoplasmic reticulum Ca2+ content as compared with control. In the presence of isoproterenol, rhythmically paced, miR-1–overexpressing myocytes exhibited spontaneous arrhythmogenic oscillations of intracellular Ca2+, events that occurred rarely in control myocytes under the same conditions. The effects of miR-1 were completely reversed by the CaMKII inhibitor KN93. Although phosphorylation of phospholamban was not altered, miR-1 overexpression increased phosphorylation of the ryanodine receptor (RyR2) at S2814 (CaMKII) but not at S2808 (protein kinase A). Overexpression of miR-1 was accompanied by a selective decrease in expression of the protein phosphatase PP2A regulatory subunit B56{alpha} involved in PP2A targeting to specialized subcellular domains. We conclude that miR-1 enhances cardiac excitation–contraction coupling by selectively increasing phosphorylation of the L-type and RyR2 channels via disrupting localization of PP2A activity to these channels.


Key words: ryanodine receptor • miR-1 CaMKII • PP2A • arrhythmia


Related Article:

Ca2+ Signaling Domains Responsible For Cardiac Hypertrophy and Arrhythmias
Steven R. Houser
Circ. Res. 2009 104: 413-415. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
Y. Lu, Y. Zhang, H. Shan, Z. Pan, X. Li, B. Li, C. Xu, B. Zhang, F. Zhang, D. Dong, et al.
MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection
Cardiovasc Res, December 1, 2009; 84(3): 434 - 441.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
B. Schroen and S. Heymans
MicroRNAs and Beyond: The Heart Reveals Its Treasures
Hypertension, December 1, 2009; 54(6): 1189 - 1194.
[Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
E. M. C. Ohlsson Teague, C. G. Print, and M. L. Hull
The role of microRNAs in endometriosis and associated reproductive conditions
Hum. Reprod. Update, September 22, 2009; (2009) dmp034v1.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Goette
Nicotine, atrial fibrosis, and atrial fibrillation: do microRNAs help to clear the smoke?
Cardiovasc Res, August 1, 2009; 83(3): 421 - 422.
[Full Text] [PDF]


Home page
Circ. Res.Home page
S. R. Houser
Ca2+ Signaling Domains Responsible For Cardiac Hypertrophy and Arrhythmias
Circ. Res., February 27, 2009; 104(4): 413 - 415.
[Full Text] [PDF]